脂肪生成
癌症研究
基因沉默
下调和上调
HDAC3型
重编程
脱甲基酶
组蛋白脱乙酰基酶
肝细胞癌
基因敲除
脂质代谢
生物
化学
表观遗传学
组蛋白
内分泌学
细胞培养
细胞
基因
生物化学
遗传学
作者
Yang Yang,Jingjing Luo,Zhongyu Wang,Kaiyue Liu,Keyi Feng,Fang Wang,Yide Mei
出处
期刊:Cancer Research
[American Association for Cancer Research]
日期:2024-12-05
被引量:1
标识
DOI:10.1158/0008-5472.can-24-1630
摘要
Abstract The tumor microenvironment plays a pivotal role in the metabolic reprogramming of cancer cells. A better understanding of the underlying mechanisms regulating cancer metabolism could help identify potential therapeutic targets. Here, we identified circEPB41(2) as a metabolically regulated circular RNA that mediates lipid metabolism in hepatocellular carcinoma (HCC). CircEPB41(2) was induced in response to glucose deprivation via HNRNPA1-dependent alternative splicing. Upregulation of circEPB41(2) led to enhanced lipogenic gene expression that promoted lipogenesis. Mechanistically, circEPB41(2) cooperated with the m6A demethylase FTO to decrease the mRNA stability of the histone deacetylase SIRT6, thereby increasing H3K9ac and H3K27ac levels to activate lipogenic gene expression. Silencing of circEPB41(2) inhibited both in vitro proliferation of HCC cells and in vivo growth of tumor xenografts. Clinically, circEPB41(2) was elevated in HCC, and high circEPB41(2) expression was associated with poor patient prognosis. Overall, this study reveals that circEPB41(2) is an important regulator of lipid metabolic reprogramming and indicates that targeting the circEPB41(2)-FTO-SIRT6 axis could represent a promising anti-cancer strategy for treating HCC.
科研通智能强力驱动
Strongly Powered by AbleSci AI